Fenelidone (Keshenda) dosage adjustment principles and individualized medication recommendations

Finerenone is a new type of selective mineral corticoid receptor antagonist, mainly used in patients with chronic kidney disease and type 2 diabetes to reduce proteinuria and delay the decline of renal function. Due to individual differences in renal function, blood pressure and electrolyte levels among patients, dose adjustment principles and individualized medication recommendations are very important in clinical application to ensure efficacy while reducing the risk of adverse reactions.

Generally, the starting dose of fenelidone is based on the patient's renal function and serum potassium levels. For patients with normal renal function and normal serum potassium, they can start with the standard dose; for patients with mild to moderate renal impairment or with blood potassium close to the upper limit, doctors will recommend starting with a lower dose. After the initial dose is adjusted, serum potassium and renal function indicators should be rechecked within 4 weeks or at intervals recommended by the doctor to determine whether the dose needs to be increased or maintained.

In terms of individualized medication, the patient's blood pressure status, history of heart failure, and other concomitant medications should be comprehensively considered. Fennelidone may cause hyperkalemia, especially when used concomitantly with ACE inhibitors, ARBs, or other potassium-sparing drugs. Therefore, it is often clinically recommended to closely monitor serum potassium in the early stages of treatment and adjust the dose based on the monitoring results. For patients with low blood pressure or who are prone to hypotension, the risk can be reduced by delaying dose escalation or maintaining a low-dose regimen.

In addition, patient education is also an important part of personalized medicine. Patients and their families should understand the importance of taking medications regularly as prescribed by the doctor, and regularly review serum potassium, blood pressure and renal function indicators. In the event of hyperkalemia or deterioration of renal function, a doctor should be contacted promptly. Through scientific dosage adjustment principles and individualized medication regimens, fenelidone can maximize its efficacy in reducing proteinuria and delaying the decline of renal function while ensuring safety.

Reference materials:https://www.drugs.com/